ANC-501 in the Treatment of Adults With Major Depressive Disorder

Clinical trial NCT05439603 · COMPLETED

Trial details

NCT number: NCT05439603
Sponsor: Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2022-09-19
Primary completion: 2023-08-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.